Loading stock data...

Evoq Remedies Limited

BSE: EVOQ

BSE
3.95 -0.20 (-4.82%)

Prev Close

4.15

Open Price

3.95

Volume

52,000

Today Low / High

3.95 / 4.3

52 WK Low / High

2.11 / 8.28

Range

4 - 4

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 3.95, reflecting a change of -0.2 (-4.81928%). The expected target range on the BSE is 4 - 4. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

30 Sep 3.95 0.00%
29 Sep 4.15 0.00%
26 Sep 4.36 0.00%
25 Sep 4.44 3.15%
24 Sep 4.17 6.95%
23 Sep 4.49 -7.13%
22 Sep 4.27 0.00%
19 Sep 3.65 6.58%
18 Sep 3.65 -1.92%
17 Sep 3.58 0.00%
16 Sep 3.50 -0.86%
15 Sep 3.62 0.00%
12 Sep 3.69 0.00%
11 Sep 3.77 -2.39%
10 Sep 3.95 -4.56%
09 Sep 4.20 -8.10%
08 Sep 4.14 -3.38%
05 Sep 3.87 0.00%
04 Sep 3.90 -6.15%
03 Sep 3.90 -5.90%
02 Sep 3.71 -2.96%

Evoq Remedies Limited Graph

Evoq Remedies Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Evoq Remedies Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 3.95, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 3.95 3.99 3.59 - 4.39
4.03 3.22 - 4.83
4.07 2.85 - 5.29
Bearish Scenario 3.95 3.91 3.52 - 4.30
3.87 3.10 - 4.65
3.83 2.68 - 4.98

Overview of Evoq Remedies Limited

ISIN

INE0JVD01011

Industry

Medical - Pharmaceuticals

Vol.Avg

48,137

Market Cap

98,355,000

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

N/A

DCF

0

Financial Ratios Every Investor Needs

Stock Rating Details for EVOQ

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 11.76 Cr 13.08 Cr -1.32 Cr -0.1127 0.00 Cr 0.00 Cr -2.29 Cr 0.09 Cr 0.06 0.18 Cr 0.0075
2024-03-31 6.31 Cr 1.57 Cr 4.74 Cr 0.7518 0.00 Cr 0.08 Cr 4.29 Cr 0.45 Cr 0.33 0.62 Cr 0.0717
2023-03-31 26.41 Cr 19.33 Cr 7.08 Cr 0.2682 0.00 Cr 0.22 Cr 2.29 Cr 1.62 Cr 1.19 2.29 Cr 0.0613
2022-03-31 16.78 Cr 13.81 Cr 2.98 Cr 0.1774 0.00 Cr 0.19 Cr 1.46 Cr 1.09 Cr 1.09 0.00 Cr 0.0650
2021-03-31 10.02 Cr 7.86 Cr 2.16 Cr 0.2158 0.00 Cr 0.00 Cr 0.95 Cr 0.72 Cr 7.15 0.00 Cr 0.0714

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.21 Cr 50.01 Cr 5.47 Cr 44.5360 Cr 0.00 Cr -0.21 Cr 2.22 Cr 0.22 Cr 0.00 Cr 0.00 Cr 0.00 Cr 5.4734 Cr
2024-03-31 0.12 Cr 36.86 Cr 11.62 Cr 25.2378 Cr 4.24 Cr 4.11 Cr 3.13 Cr 0.01 Cr 0.00 Cr 0.00 Cr 0.00 Cr 11.6232 Cr
2023-03-31 0.15 Cr 34.90 Cr 10.11 Cr 24.7855 Cr 9.58 Cr 9.42 Cr 2.03 Cr 0.01 Cr 0.00 Cr 0.00 Cr 0.00 Cr 10.1130 Cr
2022-03-31 3.09 Cr 33.33 Cr 10.17 Cr 23.1663 Cr 8.16 Cr 5.06 Cr 0.78 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 10.1651 Cr
2021-03-31 0.03 Cr 8.05 Cr 7.30 Cr 0.7430 Cr 0.00 Cr -0.03 Cr 0.15 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 7.3021 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -14.6230 Cr -0.2581 Cr 14.9718 Cr -14.8811 Cr 0.0907 Cr 0.2141 Cr -0.2581 Cr 0.1282 Cr -4.2382 Cr 0.0000 Cr 0.9060 Cr
2024-03-31 5.3198 Cr -0.0120 Cr -5.3380 Cr 5.3078 Cr -0.0302 Cr 0.1234 Cr -0.0120 Cr 0.6114 Cr 0.0000 Cr 0.0000 Cr -1.0929 Cr
2023-03-31 -4.3457 Cr -0.0131 Cr 1.4182 Cr -4.3588 Cr -1.7319 Cr 0.1536 Cr -0.0131 Cr 1.6193 Cr 0.0000 Cr 0.0000 Cr -1.2477 Cr
2022-03-31 -27.6378 Cr 0.0000 Cr 29.4900 Cr -27.6378 Cr 1.8522 Cr 1.8855 Cr 0.0000 Cr 1.0913 Cr 0.0000 Cr 0.0000 Cr -0.6338 Cr
2021-03-31 0.0311 Cr 0.0000 Cr 0.0000 Cr 0.0311 Cr 0.0311 Cr 0.0333 Cr 0.0000 Cr 0.7154 Cr 0.0000 Cr 0.0000 Cr -0.0901 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2024-03-31 1.20 Cr 0.37 Cr 0.84 Cr 0.6952 0.64 Cr 0.20 Cr 0.14 0.27 Cr 0.1672
2023-12-31 1.20 Cr 0.37 Cr 0.83 Cr 0.6917 0.27 Cr 0.20 Cr 0.14 0.27 Cr 0.1672
2023-09-30 1.95 Cr 1.15 Cr 0.80 Cr 0.4109 0.03 Cr 0.03 Cr 0.02 0.04 Cr 0.0128
2023-06-30 1.95 Cr 1.15 Cr 0.80 Cr 0.4109 0.03 Cr 0.03 Cr 0.02 0.04 Cr 0.0128
2023-03-31 5.31 Cr 2.11 Cr 3.20 Cr 0.6018 0.99 Cr 0.66 Cr 0.48 0.99 Cr 0.1236

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 0.21 Cr 0.00 Cr 0.21 Cr 36.53 Cr 2.22 Cr 49.79 Cr 0.22 Cr 50.01 Cr 5.47 Cr
2024-09-30 0.26 Cr 0.00 Cr 0.26 Cr 33.81 Cr 1.56 Cr 47.53 Cr 0.01 Cr 47.54 Cr 4.72 Cr
2024-03-31 0.12 Cr 0.00 Cr 0.12 Cr 33.28 Cr 3.13 Cr 36.85 Cr 0.01 Cr 36.86 Cr 11.62 Cr
2023-12-31 0.12 Cr 0.00 Cr 0.12 Cr 1.74 Cr 3.13 Cr 36.85 Cr 0.01 Cr 36.86 Cr 11.62 Cr
2023-09-30 0.06 Cr 0.00 Cr 0.06 Cr 11.14 Cr 1.56 Cr 30.79 Cr 0.02 Cr 30.81 Cr 5.97 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-03-31 0.20 Cr -1.45 Cr 0.00 Cr 1.48 Cr 0.03 Cr 0.03 Cr 0.00 Cr 0.00 Cr -1.45 Cr
2023-12-31 0.20 Cr -1.45 Cr 0.00 Cr 1.48 Cr 0.03 Cr 0.03 Cr 0.00 Cr 0.00 Cr -1.45 Cr
2023-09-30 0.03 Cr 4.11 Cr -0.01 Cr -4.15 Cr -0.05 Cr -0.05 Cr 0.00 Cr -0.01 Cr 4.10 Cr
2023-06-30 0.03 Cr 4.11 Cr -0.01 Cr -4.15 Cr -0.05 Cr -0.05 Cr 0.00 Cr -0.01 Cr 4.10 Cr
2023-03-31 0.66 Cr 0.58 Cr -0.01 Cr -0.52 Cr 0.06 Cr 0.06 Cr 0.00 Cr -0.01 Cr 0.58 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹757.45 ₹90,699,863,293.00 ₹78,304.00

Key Executives

MD & Director
Mr. Bhumishth Narendrabhai Patel

Gender: male

Year Born: 1983

Chief Financial Officer
Mr. Yogesh M. Rajput

Gender: male

Year Born:

FAQs about Evoq Remedies Limited

Who is the CEO of the company?

The CEO is Bhumishth Narendrabhai Patel.

What is the current market price of the stock?

The current price is ₹3.95.

What is the 52-week price range?

The range is ₹2.11-8.28.

What is the market capitalization of the company?

The market capitalization is ₹9.84 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 61.40.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Evoq Remedies Limited (ISIN: INE0JVD01011) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹9.84 crores and an average daily volume of 48,137 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.